Confirm eligibility
Apply only if:
- your organization is legally identifiable;
- you are authorized to submit on its behalf;
- the organization controls or has documented permission to submit the formula;
- the formula is complete and stable enough to review;
- target population, intended use, serving, directions, label, evidence, safety, and quality records are available;
- you can accept public registry, change-notification, surveillance, and mark-use terms;
- you can disclose material matters requested by the program.
Choose the Market-Ready Formulation or Marketed Product track according to the current record.
Evidence checklist
Applicant and authority
- legal entity record and address;
- authorized contact and signer;
- formula ownership, license, or submission authority;
- responsible company and relevant relationships;
- conflicts and material connections with ASA, reviewers, consultants, labs, or sponsors.
Formula file
- exact version identifier and date;
- complete quantitative composition;
- ingredient form, source, standardization, carrier, overage, and relevant excipients;
- serving size, daily servings, format, directions, and intended duration;
- target population and exclusions.
Rationale and evidence
- intended purpose;
- ingredient-by-ingredient rationale;
- combination rationale;
- evidence map with complete citations;
- assessment of relevance, quality, consistency, and limitations;
- contrary or limiting evidence and explanation of extrapolation.
Safety
- hazard and tolerability review;
- total daily exposure;
- reference-level or upper-level analysis where relevant;
- contraindications, interactions, allergens, and vulnerable populations;
- safety warnings and label communication;
- relevant product experience for a marketed product.
Quality
- raw-material and finished-product specifications;
- identity and other methods relevant to acceptance;
- supplier and material controls;
- contaminants, adulterants, microbiological, physical, and chemical risk controls;
- process factors material to the formula;
- stability protocol or evidence and packaging rationale;
- change-control and traceability information.
Label and communication
- current or proposed label artwork or controlled text;
- every claim submitted for review;
- substantiation and qualifications;
- proposed public product/formula description;
- website or marketing examples requested for the Marketed Product track.
Material disclosures
- relevant recalls, safety signals, government actions, litigation, or disputes within the defined application scope;
- prior recognition, certification, or review material to public understanding;
- third-party testing or consulting relationships represented in the application.
Before uploading confidential material
Read the application privacy and confidentiality terms. Identify trade-secret material according to the submission instructions and provide a separate public description. Do not upload patient-identifiable information, unnecessary personal data, payment-card data, or records you do not have a right to share.
ASA restricts evidence to authorized operations, reviewers, decision makers, and service providers. Confidentiality remains subject to law, security, fair process, and the program terms.
Application steps
1. Create an authorized account
Verify email and organization, use a personal credential, and accept the current application terms.
2. Complete scope screening
Identify track, formula, version, population, purpose, and responsible entity. The screening determines whether the application can proceed; it is not recognition.
3. Upload and map evidence
Use structured fields and the evidence map rather than a single undifferentiated document archive. Cite each claim and criterion to the relevant record.
4. Attest and submit
The authorized signer confirms accuracy, authority, completeness, disclosures, change obligations, and public registry terms. The final action should show exactly what will be submitted.
5. Completeness review
ASA acknowledges receipt and identifies missing or inconsistent information. An application enters substantive review only after acceptance as complete.
6. Review and clarification
Qualified, conflict-screened reviewers assess the current criteria. ASA may issue a consolidated clarification request with a response date.
7. Decision and next action
The applicant receives a written decision. A recognized record is not active until factual registry fields and mark terms are complete.
Timing and status
Timing targets will be published after the operating process has been measured. Applicant status is available through the secure portal. Review time varies with completeness, subject complexity, conflict resolution, clarification, and decision review.
No application fee
ASA does not charge to submit or renew a NutraFormula application under this program model. Optional promotional or event opportunities, if offered separately, do not affect review and must not be bundled as a condition of recognition.
Applicant support
Support can explain scope, fields, evidence format, portal use, and process. It cannot promise an outcome, select evidence for the applicant, design the formula, or provide legal or medical advice.
Submit when the record is complete
To prepare the required record, review the evidence checklist.
Begin an award application inquiry
Provide initial contact and product-category information. ASA will return instructions for the secure evidence channel.